Effect of Calciterol and Cinacalcate on hyperparathyroidism
Phase 3
- Conditions
- Hyperparathyroidism.Hyperparathyroidism and other disorders of parathyroid gland
- Registration Number
- IRCT20190702044076N1
- Lead Sponsor
- Shahre-kord University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Consent to participate in the study
Having end-stage renal disease
Patients undergoing hemodialysis
Exclusion Criteria
Parathyroid hormone less than 300 pg / ml
Calcium higher than 10 mg / dl
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Phosphate. Timepoint: Before the intervention and 8 weeks after the intervention. Method of measurement: Serum levels of blood sample.;Parathyroid hormone. Timepoint: Before the intervention and 8 weeks after the intervention. Method of measurement: Serum levels of blood sample.;Calcium. Timepoint: Before the intervention and 8 weeks after the intervention. Method of measurement: Serum levels of blood sample.
- Secondary Outcome Measures
Name Time Method